Renovaro Bio tumbles as Hindenburg takes short position

Lunai Bioworks

13/02/2024 15:31

** Shares of biotech Renovaro BioSciences  RENB.O  down 27%
at $2.47
    ** Stock also briefly halted due to volatility during
trading hours 
    ** Short-seller Hindenburg Research says has taken short
position in co 
    ** It raises concerns over co's executive leadership, says
it sees "inevitable massive downside in shares" of RENB
    ** RENB did not immediately respond to a Reuters' request
for comment 
    ** Including session moves, RENB down 22% YTD 

 (Reporting by Bhanvi Satija in Bengaluru)
 ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))